shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: In vitro and in vivo experiments
Lung neoplasms; Receptor, IGF type 1; RNA interfercnce
Indexed keywords
CASPASE 3;
MESSENGER RNA;
MITOGEN ACTIVATED PROTEIN KINASE 1;
MITOGEN ACTIVATED PROTEIN KINASE 3;
PROTEIN BCL 2;
PROTEIN KINASE B;
SHORT HAIRPIN RNA;
SOMATOMEDIN C RECEPTOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
CANCER CELL CULTURE;
CANCER INHIBITION;
CANCER SIZE;
CELL ACTIVITY;
CELL CYCLE G0 PHASE;
CELL CYCLE G1 PHASE;
CELL CYCLE G2 PHASE;
CELL CYCLE M PHASE;
CELL CYCLE S PHASE;
CONTROLLED STUDY;
ENZYME PHOSPHORYLATION;
FLOW CYTOMETRY;
GENE EXPRESSION REGULATION;
GENE SILENCING;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
LUNG NON SMALL CELL CANCER;
MITOSIS INHIBITION;
MOUSE;
NICK END LABELING;
NONHUMAN;
NUDE MOUSE;
PLASMID;
PROTEIN EXPRESSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RNA INTERFERENCE;
RNA SEQUENCE;
WESTERN BLOTTING;
Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
Kulik G, Klippel A, Weber MJ. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol, 1997, 17:1595-1606.
An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation
Maloney EK, McLaughlin JL, Dagdigian NE, et al. An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res, 2003, 63:5073-5083.
Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effectors on lung cancer
Lee CT, Park KH, Adachi Y, et al. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effectors on lung cancer. Cancer Gene Ther, 2003, 10:57-63.
Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on tumor lung cancer cell lines
Lee CT, Wu S, Gabrilovich D, et al. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on tumor lung cancer cell lines. Cancer Res, 1996, 56:3038-3041.
Bohula EA, Salisbury AJ, Sohail M, et al. The efficacy of small interfering RNNs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J Biol Chem, 2003, 278-15991-15997.
Bohula EA, Salisbury AJ, Sohail M, et al. The efficacy of small interfering RNNs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J Biol Chem, 2003, 278-15991-15997.
7
0028957113
Molecular and cellular aspects of the insulin-like growth factor I receptor
LeRoith D, Werner H, Beitner-Johnson D, et al. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev, 1995, 16:143-163.
U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells
Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol, 2002, 20:497-500.
Positional efects, of short interfering RNAs targeting the human coagulation trigger tissue factor
Holen T, Amarzguioui M, Wiiger MT, et al. Positional efects, of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res, 2002, 30:1757-1766.
